Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 7
1965 1
1967 1
1968 1
1970 3
1971 4
1972 2
1973 7
1974 4
1975 2
1976 4
1978 4
1979 2
1980 2
1981 1
1982 2
1983 2
1984 1
1985 2
1986 1
1987 1
1988 5
1989 3
1991 2
1992 1
1993 4
1994 2
1995 2
1996 3
1997 4
1998 8
1999 21
2000 48
2001 74
2002 66
2003 89
2004 62
2005 76
2006 75
2007 68
2008 75
2009 55
2010 53
2011 50
2012 35
2013 59
2014 51
2015 43
2016 41
2017 37
2018 41
2019 43
2020 41
2021 42
2022 39
2023 15

Text availability

Article attribute

Article type

Publication date

Search Results

1,304 results

Results by year

Filters applied: . Clear all
Page 1
Lipodystrophy Syndromes.
Hussain I, Garg A. Hussain I, et al. Endocrinol Metab Clin North Am. 2016 Dec;45(4):783-797. doi: 10.1016/j.ecl.2016.06.012. Epub 2016 Oct 6. Endocrinol Metab Clin North Am. 2016. PMID: 27823605 Free PMC article. Review.
The two most common genetic varieties include congenital generalized lipodystrophy and familial partial lipodystrophy; the two most common acquired varieties include acquired generalized lipodystrophy and acquired partial lipodystrophy. Highly active a …
The two most common genetic varieties include congenital generalized lipodystrophy and familial partial lipodystrophy; the two …
Diagnosis and treatment of lipodystrophy: a step-by-step approach.
Araújo-Vilar D, Santini F. Araújo-Vilar D, et al. J Endocrinol Invest. 2019 Jan;42(1):61-73. doi: 10.1007/s40618-018-0887-z. Epub 2018 Apr 27. J Endocrinol Invest. 2019. PMID: 29704234 Free PMC article. Review.
PURPOSE: To describe the clinical presentation of known types of lipodystrophy, and suggest specific steps to recognize, diagnose and treat lipodystrophy in the clinical setting. ...CONCLUSIONS: Here, we describe the clinical presentation of known types of lipody
PURPOSE: To describe the clinical presentation of known types of lipodystrophy, and suggest specific steps to recognize, diagnose and …
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.
Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, Mungai L, Oral EA, Patni N, Rother KI, von Schnurbein J, Sorkina E, Stanley T, Vigouroux C, Wabitsch M, Williams R, Yorifuji T. Brown RJ, et al. J Clin Endocrinol Metab. 2016 Dec;101(12):4500-4511. doi: 10.1210/jc.2016-2466. Epub 2016 Oct 6. J Clin Endocrinol Metab. 2016. PMID: 27710244 Free PMC article. Review.
This practice guideline summarizes the diagnosis and management of lipodystrophy syndromes not associated with HIV or injectable drugs. ...Diet is essential for the management of metabolic complications of lipodystrophy. Metreleptin therapy is effective for metaboli …
This practice guideline summarizes the diagnosis and management of lipodystrophy syndromes not associated with HIV or injectable drug …
Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome.
Kahn CR, Wang G, Lee KY. Kahn CR, et al. J Clin Invest. 2019 Oct 1;129(10):3990-4000. doi: 10.1172/JCI129187. J Clin Invest. 2019. PMID: 31573548 Free PMC article. Review.
These inter- and intra-depot differences in adipocytes are developmentally programmed and contribute to the wide range of effects observed in disorders with fat excess (overweight/obesity) or fat loss (lipodystrophy). Recent studies also highlight the underappreciated dyna …
These inter- and intra-depot differences in adipocytes are developmentally programmed and contribute to the wide range of effects observed i …
Molecular and Cellular Bases of Lipodystrophy Syndromes.
Zammouri J, Vatier C, Capel E, Auclair M, Storey-London C, Bismuth E, Mosbah H, Donadille B, Janmaat S, Fève B, Jéru I, Vigouroux C. Zammouri J, et al. Front Endocrinol (Lausanne). 2022 Jan 3;12:803189. doi: 10.3389/fendo.2021.803189. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35046902 Free PMC article. Review.
Lipodystrophy syndromes are rare diseases originating from a generalized or partial loss of adipose tissue. ...We will discuss the links between lipodystrophy and premature ageing and/or immuno-inflammatory aggressions of adipose tissue, as well as the relationships
Lipodystrophy syndromes are rare diseases originating from a generalized or partial loss of adipose tissue. ...We will discuss the li
Lipodystrophy for the Diabetologist-What to Look For.
Patni N, Garg A. Patni N, et al. Curr Diab Rep. 2022 Sep;22(9):461-470. doi: 10.1007/s11892-022-01485-w. Epub 2022 Jul 11. Curr Diab Rep. 2022. PMID: 35821558 Review.
In this review, we discuss the various subtypes and when to suspect and how to diagnose lipodystrophy. RECENT FINDINGS: The four major subtypes are autosomal recessive, congenital generalized lipodystrophy (CGL); acquired generalized lipodystrophy (AGL), most …
In this review, we discuss the various subtypes and when to suspect and how to diagnose lipodystrophy. RECENT FINDINGS: The four majo …
Cutaneous Manifestations of Diabetes.
Hines A, Alavi A, Davis MDP. Hines A, et al. Med Clin North Am. 2021 Jul;105(4):681-697. doi: 10.1016/j.mcna.2021.04.008. Med Clin North Am. 2021. PMID: 34059245 Review.
Severe insulin resistance syndromes.
Angelidi AM, Filippaios A, Mantzoros CS. Angelidi AM, et al. J Clin Invest. 2021 Feb 15;131(4):e142245. doi: 10.1172/JCI142245. J Clin Invest. 2021. PMID: 33586681 Free PMC article. Review.
This Review aims to categorize severe insulin resistance syndromes by disease process, including insulin receptor defects, signaling defects, and lipodystrophies. We also highlight several complex syndromes and emphasize the need to identify patients, investigate underlyin …
This Review aims to categorize severe insulin resistance syndromes by disease process, including insulin receptor defects, signaling defects …
Familial partial lipodystrophy syndromes.
Fernández-Pombo A, Sánchez-Iglesias S, Cobelo-Gómez S, Hermida-Ameijeiras Á, Araújo-Vilar D. Fernández-Pombo A, et al. Presse Med. 2021 Nov;50(3):104071. doi: 10.1016/j.lpm.2021.104071. Epub 2021 Oct 2. Presse Med. 2021. PMID: 34610417 Review.
Lipodystrophies are a heterogeneous group of rare conditions characterised by the loss of adipose tissue. ...Although no well-defined diagnostic criteria have been established for lipodystrophy, there are certain clues related to medical history, physical examinatio
Lipodystrophies are a heterogeneous group of rare conditions characterised by the loss of adipose tissue. ...Although no well-defined
Lipodystrophies-Disorders of the Fatty Tissue.
Knebel B, Müller-Wieland D, Kotzka J. Knebel B, et al. Int J Mol Sci. 2020 Nov 20;21(22):8778. doi: 10.3390/ijms21228778. Int J Mol Sci. 2020. PMID: 33233602 Free PMC article. Review.
Lipodystrophies are a heterogeneous group of physiological changes characterized by a selective loss of fatty tissue. ...Experimental animal models are therefore useful to understand the molecular mechanisms in lipodystrophy and to identify possible therapeutic appr
Lipodystrophies are a heterogeneous group of physiological changes characterized by a selective loss of fatty tissue. ...Experimental
1,304 results